Antiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells.

Norton, Kerri-Ann; Han, Zheyi; Popel, Aleksander S; Pandey, Niranjan B

Norton, Kerri-Ann; Han, Zheyi; Popel, Aleksander S; Pandey, Niranjan B.

Afiliação

Norton KA; Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Han Z; Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Popel AS; Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA ; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Pandey NB; Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Onco Targets Ther ; 7: 1571-82, 2014.

Article em En | MEDLINE | ID: mdl-25228815

Palavras-chave

VEGFA; VEGFRs; angiogenesis; flow cytometry; sunitinib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos